Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Entity) (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 722.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 133.73 Mn
Mar 31, 2026 133.44 Mn
Dec 31, 2025 132.38 Mn
Sep 30, 2025 131.79 Mn
Jun 30, 2025 130.98 Mn
Mar 31, 2025 130.31 Mn
Dec 31, 2024 129.29 Mn
Sep 30, 2024 128.84 Mn
Jun 30, 2024 128.02 Mn
Mar 31, 2024 126.46 Mn
Dec 31, 2023 125.79 Mn
Sep 30, 2023 125.45 Mn
Jun 30, 2023 124.90 Mn
Mar 31, 2023 124.24 Mn
Dec 31, 2022 123.93 Mn
Sep 30, 2022 122.99 Mn
Jun 30, 2022 120.99 Mn
Mar 31, 2022 120.73 Mn
Dec 31, 2021 120.18 Mn
Sep 30, 2021 119.48 Mn